Evidence map›Paper›PMID 18514638›Full record

ArticleBrain research2008

Sensory effects of intravenous cocaine on dopamine and non-dopamine ventral tegmental area neurons.

P Leon Brown, Eugene A Kiyatkin

Open access · greenAbstract read
In one paragraph

Article in Brain research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Cocaine increases dopaminergic neuron and motor activity via midbrain α1 adrenergic signaling.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
  3. A subpopulation of neurochemically-identified ventral tegmental area dopamine neurons is excited by intravenous cocaine.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  4. Article
  5. Article
  6. Rapid sensitization of physiological, neuronal, and locomotor effects of nicotine: critical role of peripheral drug actions.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  7. Article
  8. Article
  9. Differentiating the rapid actions of cocaine.Nature reviews. Neuroscience · 2011
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

P Leon BrownBehavioral Neuroscience Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, DHHS, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA.
Eugene A Kiyatkin
National Institute on Drug Abuse · USNational Institutes of Health · US

Funding

Brain Temperature, Reward, And Drugs Of AbuseZIADA000445 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI KIYATKIN, EUGENE A · 2009 to 2020
$4.1M
Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

Intravenous (iv) cocaine mimics salient somato-sensory stimuli in their ability to induce rapid physiological effects, which appear to involve its action on peripherally located neural elements and fast neural transmission via somato-sensory pathways. To further clarify this mechanism, single-unit recording with fine glass electrodes was used in awake rats to examine responses of ventral tegmental area (VTA) neurons, both presumed dopamine (DA) and non-DA, to iv cocaine and tail-press, a typical somato-sensory stimulus. To exclude the contribution of DA mechanisms to the observed neuronal responses to sensory stimuli and cocaine, recordings were conducted during full DA receptor blockade (SCH23390+eticloptide). Iv cocaine (0.25 mg/kg delivered over 10 s) induced significant excitations of approximately 63% of long-spike (presumed DA) and approximately 70% of short-spike (presumed non-DA) VTA neurons. In both subgroups, neuronal excitations occurred with short latencies (4-8 s), peaked at 10-20 s (30-40% increase over baseline) and disappeared at 30-40 s after the injection onset. Most long-(67%) and short-spike (89%) VTA neurons also showed phasic responses to tail-press (5-s). All responsive long-spike cells were excited by tail-press; excitations were very rapid (peak at 1 s) and strong (100% rate increase over baseline) but brief (2-3 s). In contrast, both excitations (60%) and inhibitions (29%) were seen in short-spike cells. These responses were also rapid and transient, but excitations of short-spike units were more prolonged and sustained (10-15 s) than in long-spike cells. These data suggest that in awake animals iv cocaine, like somato-sensory stimuli, rapidly and transiently excites VTA neurons of different subtypes. Therefore, along with direct action on specific brain substrates, central effects of cocaine may occur, via an indirect mechanism, involving peripheral neural elements, visceral sensory nerves and rapid neural transmission. Via this mechanism, cocaine, like somato-sensory stimuli, can rapidly activate DA neurons and induce phasic DA release, creating the conditions for DA accumulation by a later occurring and prolonged direct inhibiting action on DA uptake. By providing a rapid neural signal and triggering transient neural activation, such a peripherally driven action might play a crucial role in the sensory effects of cocaine, thus contributing to learning and development of drug-taking behavior.

Indexed as

NeuronsAction PotentialsAfferent PathwaysAnalysis of VarianceAnimalsCocaineDopamineDopamine AntagonistsDopamine Uptake InhibitorsImidazolesInjections, IntravenousMalePhysical StimulationRatsRats, Long-EvansSalicylamidesCocaineDopamineDopamine AntagonistsDopamine Uptake InhibitorseticloprideImidazolesSalicylamidesSch 28080

Identifiers

PMID18514638
PMCPMC2527219
OpenAlexW1965358244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.